For lung carcinoma, S100A4 expression was associated with worse survival outcomes in NSCLC and promoted cancer invasion through the NF‐κB/MMP9 signaling pathway.[62, 63] Recently, Liu et al. Here, S100A4 is linked to non-small cell lung carcinoma.